NO974846L - Fremgangsmåte for fremstilling av Form 1 Ranitidin-Hydroklorid - Google Patents

Fremgangsmåte for fremstilling av Form 1 Ranitidin-Hydroklorid

Info

Publication number
NO974846L
NO974846L NO974846A NO974846A NO974846L NO 974846 L NO974846 L NO 974846L NO 974846 A NO974846 A NO 974846A NO 974846 A NO974846 A NO 974846A NO 974846 L NO974846 L NO 974846L
Authority
NO
Norway
Prior art keywords
ranitidine hydrochloride
preparation
ranitidine
hydrochloride
methyl
Prior art date
Application number
NO974846A
Other languages
English (en)
Norwegian (no)
Other versions
NO974846D0 (no
Inventor
Helmut Schickaneder
Aggelos Nikolopoulos
Original Assignee
Hexal Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Pharmaceuticals Inc filed Critical Hexal Pharmaceuticals Inc
Publication of NO974846D0 publication Critical patent/NO974846D0/no
Publication of NO974846L publication Critical patent/NO974846L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO974846A 1995-04-21 1997-10-20 Fremgangsmåte for fremstilling av Form 1 Ranitidin-Hydroklorid NO974846L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/426,930 US5663381A (en) 1995-04-21 1995-04-21 Process for preparing form 1 ranitidine hydrochloride
PCT/US1996/000992 WO1996033185A1 (en) 1995-04-21 1996-01-26 A process for preparing form 1 ranitidine hydrochloride

Publications (2)

Publication Number Publication Date
NO974846D0 NO974846D0 (no) 1997-10-20
NO974846L true NO974846L (no) 1997-12-19

Family

ID=23692783

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974846A NO974846L (no) 1995-04-21 1997-10-20 Fremgangsmåte for fremstilling av Form 1 Ranitidin-Hydroklorid

Country Status (17)

Country Link
US (1) US5663381A (cs)
JP (1) JPH11503755A (cs)
KR (1) KR19990007912A (cs)
AU (1) AU691736B2 (cs)
BG (1) BG101982A (cs)
BR (1) BR9608177A (cs)
CA (1) CA2218562A1 (cs)
CZ (1) CZ332097A3 (cs)
EE (1) EE9700291A (cs)
FI (1) FI974002A7 (cs)
HU (1) HUP9801658A2 (cs)
NO (1) NO974846L (cs)
NZ (1) NZ302872A (cs)
PL (1) PL322979A1 (cs)
SI (1) SI9620056A (cs)
SK (1) SK143697A3 (cs)
WO (1) WO1996033185A1 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004985A (en) * 1996-10-09 1999-12-21 Berlex Laboratories, Inc. Thio acid derived monocylic N-heterocyclics as anticoagulants
US6140351A (en) * 1997-12-19 2000-10-31 Berlex Laboratories, Inc. Ortho-anthranilamide derivatives as anti-coagulants
IT1317858B1 (it) * 2000-02-29 2003-07-15 Pharmexcel S R L Allomorfo del cloridrato dell'isomero z di derivato dialchilamminofurano, procedimento per la sua produzione e composizione
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
EP1652848B1 (en) * 2003-07-29 2012-02-01 Dainippon Sumitomo Pharma Co., Ltd. Process for producing imide compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US5338871A (en) * 1991-12-20 1994-08-16 Torcan Chemical Ltd. Preparation of form 1 ranitidine hydrochloride

Also Published As

Publication number Publication date
EE9700291A (et) 1998-06-15
AU4903296A (en) 1996-11-07
NO974846D0 (no) 1997-10-20
FI974002L (fi) 1997-12-03
CA2218562A1 (en) 1996-10-24
NZ302872A (en) 1998-04-27
WO1996033185A1 (en) 1996-10-24
BR9608177A (pt) 2000-10-31
MX9708122A (es) 1998-06-28
HUP9801658A2 (hu) 1999-09-28
AU691736B2 (en) 1998-05-21
FI974002A0 (fi) 1997-10-20
KR19990007912A (ko) 1999-01-25
SI9620056A (sl) 1998-04-30
CZ332097A3 (cs) 1998-03-18
US5663381A (en) 1997-09-02
BG101982A (bg) 1998-04-30
PL322979A1 (en) 1998-03-02
JPH11503755A (ja) 1999-03-30
SK143697A3 (en) 1998-05-06
FI974002A7 (fi) 1997-12-03

Similar Documents

Publication Publication Date Title
FI964682A0 (fi) Glukagonia sisältävä farmaseuttinen valmiste
NO965298L (no) Ny krystallmodifikasjon av CDCH, fremgangsmåte for fremstilling derav og farmasöytiske preparater inneholdende denne
IL108382A0 (en) Amino acid derivatives, their preparation and pharmaceutical compositions containing them
HUP0100928A2 (hu) Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
PL293795A1 (en) Method of obtaining cyclic urea derivatives
MX9801716A (es) Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.
PL313070A1 (en) Derivatives of n-(3-benzofuranyl)-urea, method of obtaining them and pharmaceutical compositions containing such derivatives
HUP9603237A2 (hu) (R)-(-)-2-{N-[4-(1,1-dioxido-3-oxo-2,3-dihidro-benzizotiazol-2-il)-butil]-amino-metil}-kromán kristályos hidrokloridja, eljárás előállítására és a vegyületeket tartalmazó gyógyszerkészítmények
DK581889A (da) Antiatherosclerotiske diarylforbindelser
TR200001519T2 (tr) İnsanlardaki Spermatozoa'nın konsantrasyonu ve/veya hareket kabiliyetini artırmak için uygulanması gerekli yöntem ve ilaç terkipleri
DE59601683D1 (de) Sulfamat-derivate von 1,3,5(10)-estratrien-derivaten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
UA42819C2 (uk) Ін`єкційний та інфузійний розчин, що містить енрофлокcацин
HUP9801977A1 (hu) Új indol- és indazolszármazékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
IL112098A0 (en) Sulfamate derivatives and pharmaceutical compositions containing them
NO974846L (no) Fremgangsmåte for fremstilling av Form 1 Ranitidin-Hydroklorid
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
NO975679D0 (no) Metode for fremstilling av N-monosubstituerte og N,N'-disubstituerte usymmetriske cykliske ureaer
BR9803914A (pt) Lantibióticos relacionados a actagardina e processos para sua preparação e uso.
PT87535A (pt) Process for the preparation of novel anf peptide derivatives and of pharmaceutical compositions containing the same
HUP9902081A2 (hu) Gyulladásgátlóként használható, kéntartalmú di(terc-butil)-fenol-vegyületek
HUP0001827A2 (hu) Kolchicin-származékok, eljárás előállításukra, valamint ezeket tartalmazó gyógyszerkészítmények, és a vegyületek alkalmazása gyógyszerkészítmények előállítására
EE03803B1 (et) a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid
HUP0004507A1 (hu) Ketolidok alkalmazása atheroszklerózissal kapcsolatos artériás trombózis- komplikációk megelőzésére alkalmas gyógyszerkészítmény előállítására
DE69318715D1 (de) Pharmakologisch aktive alpha-(tertiär-aminoethyl)-phenylmethanol-derivate
DE69834929D1 (de) Verwendung eines organspezifischen ernährungmittels